This had been rumoured for a few days, but then similarly rare creatures like big foot and aliens also get talked about. But it’s true, drugmaker Pfizer (PFE) is acquiring Wyeth (WYE) in a deal worth $68 billion — a legitimate blockbuster. Not surprisingly, like any huge deal this one’s garnered quite a slew of sceptics, still this line is impressive:
The transaction will be financed through a combination of cash, debt and stock. A consortium of banks has provided commitments for a total of $22.5 billion in debt.
What, without government guarantees or anything?
NOW WATCH: Money & Markets videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.